Loading…

Left atrial shortening fraction in fetuses with and without myocardial hypertrophy in diabetic pregnancies

Objective To test the hypothesis that, in diabetic pregnancies, left atrial shortening fraction (LASF) is decreased in fetuses with myocardial hypertrophy, compared to those without hypertrophy and to fetuses of non‐diabetic mothers. Methods Fetal echocardiography was performed in women with pre‐exi...

Full description

Saved in:
Bibliographic Details
Published in:Ultrasound in obstetrics & gynecology 2009-02, Vol.33 (2), p.182-187
Main Authors: Zielinsky, P., Luchese, S., Manica, J. L., Piccoli, A. L., Nicoloso, L. H., Leite, M. F., Hagemann, L., Busato, A., Moraes, M. R.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3494-12309a484a2033c9a97741b2a2eed1f236be03bd4de90a1d532128e2074590703
cites cdi_FETCH-LOGICAL-c3494-12309a484a2033c9a97741b2a2eed1f236be03bd4de90a1d532128e2074590703
container_end_page 187
container_issue 2
container_start_page 182
container_title Ultrasound in obstetrics & gynecology
container_volume 33
creator Zielinsky, P.
Luchese, S.
Manica, J. L.
Piccoli, A. L.
Nicoloso, L. H.
Leite, M. F.
Hagemann, L.
Busato, A.
Moraes, M. R.
description Objective To test the hypothesis that, in diabetic pregnancies, left atrial shortening fraction (LASF) is decreased in fetuses with myocardial hypertrophy, compared to those without hypertrophy and to fetuses of non‐diabetic mothers. Methods Fetal echocardiography was performed in women with pre‐existing or gestational diabetes and in non‐diabetic controls between 25 weeks' gestation and term. LASF was calculated using the formula: (end‐systolic diameter—end‐diastolic diameter)/end‐systolic diameter, and data were compared between diabetic women with and without fetal myocardial hypertrophy and controls. Results The study population comprised 53 diabetic women and 45 controls. Out of the 53 fetuses of diabetic women, 14 had myocardial hypertrophy and 39 had normal septal thickness. Gestational age at the time of examination did not differ significantly between the control group and the two diabetic subgroups (P = 0.57). Fetuses with myocardial hypertrophy presented a mean ( ± SD) LASF of 0.32 ± 0.11, those without myocardial hypertrophy 0.46 ± 0.12, and those of normal mothers 0.53 ± 0.09 (P < 0.001). A significant inverse linear correlation was observed between LASF and septal thickness (r = − 0.51, P < 0.001). Conclusions In diabetic pregnancies, LASF is lower in fetuses with myocardial hypertrophy than it is in those without hypertrophy and in fetuses of non‐diabetic women, suggesting that LASF could be a useful alternative parameter in the assessment of fetal diastolic function. Copyright © 2008 ISUOG. Published by John Wiley & Sons, Ltd.
doi_str_mv 10.1002/uog.6154
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66875737</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>66875737</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3494-12309a484a2033c9a97741b2a2eed1f236be03bd4de90a1d532128e2074590703</originalsourceid><addsrcrecordid>eNp1kE1r3DAQhkVJaTZpob-g6JKSi9PRhyXrWEKaFhZyac5Glse7Cl7LlWSC_33s7JKecppheGZe5iHkK4MbBsB_TGF3o1gpP5ANk8oUoKE8IxswCgqtDD8nFyk9AYCSQn0i58wA41yXG_K0xS5Tm6O3PU37EDMOftjRLlqXfRioH2iHeUqY6LPPe2qH9rUJU6aHOTgb23V1P48Ycwzjfl5XllmD2Ts6RtwNdnAe02fysbN9wi-nekkef939vf1dbB_u_9z-3BZOSCMLxgUYKytpOQjhjDVaS9ZwyxFb1nGhGgTRtLJFA5a1peCMV8hBy9Isj4tL8v14d4zh34Qp1wefHPa9HTBMqVaq0qUWegGvj6CLIaWIXT1Gf7BxrhnUq9d68VqvXhf02-nm1Byw_Q-eRC7A1Qmwydl-0bf8nN44zhjoqloziyP37Huc3w2sHx_uX4NfAPR3j0g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>66875737</pqid></control><display><type>article</type><title>Left atrial shortening fraction in fetuses with and without myocardial hypertrophy in diabetic pregnancies</title><source>Wiley</source><creator>Zielinsky, P. ; Luchese, S. ; Manica, J. L. ; Piccoli, A. L. ; Nicoloso, L. H. ; Leite, M. F. ; Hagemann, L. ; Busato, A. ; Moraes, M. R.</creator><creatorcontrib>Zielinsky, P. ; Luchese, S. ; Manica, J. L. ; Piccoli, A. L. ; Nicoloso, L. H. ; Leite, M. F. ; Hagemann, L. ; Busato, A. ; Moraes, M. R.</creatorcontrib><description>Objective To test the hypothesis that, in diabetic pregnancies, left atrial shortening fraction (LASF) is decreased in fetuses with myocardial hypertrophy, compared to those without hypertrophy and to fetuses of non‐diabetic mothers. Methods Fetal echocardiography was performed in women with pre‐existing or gestational diabetes and in non‐diabetic controls between 25 weeks' gestation and term. LASF was calculated using the formula: (end‐systolic diameter—end‐diastolic diameter)/end‐systolic diameter, and data were compared between diabetic women with and without fetal myocardial hypertrophy and controls. Results The study population comprised 53 diabetic women and 45 controls. Out of the 53 fetuses of diabetic women, 14 had myocardial hypertrophy and 39 had normal septal thickness. Gestational age at the time of examination did not differ significantly between the control group and the two diabetic subgroups (P = 0.57). Fetuses with myocardial hypertrophy presented a mean ( ± SD) LASF of 0.32 ± 0.11, those without myocardial hypertrophy 0.46 ± 0.12, and those of normal mothers 0.53 ± 0.09 (P &lt; 0.001). A significant inverse linear correlation was observed between LASF and septal thickness (r = − 0.51, P &lt; 0.001). Conclusions In diabetic pregnancies, LASF is lower in fetuses with myocardial hypertrophy than it is in those without hypertrophy and in fetuses of non‐diabetic women, suggesting that LASF could be a useful alternative parameter in the assessment of fetal diastolic function. Copyright © 2008 ISUOG. Published by John Wiley &amp; Sons, Ltd.</description><identifier>ISSN: 0960-7692</identifier><identifier>EISSN: 1469-0705</identifier><identifier>DOI: 10.1002/uog.6154</identifier><identifier>PMID: 19012275</identifier><language>eng</language><publisher>Chichester, UK: John Wiley &amp; Sons, Ltd</publisher><subject>Biological and medical sciences ; Cardiomegaly - diagnostic imaging ; Cardiomegaly - physiopathology ; Case-Control Studies ; Cross-Sectional Studies ; Diabetes Mellitus - diagnostic imaging ; Diabetes Mellitus - physiopathology ; Diabetes. Impaired glucose tolerance ; Echocardiography ; Endocrine pancreas. Apud cells (diseases) ; Endocrinopathies ; Etiopathogenesis. Screening. Investigations. Target tissue resistance ; Female ; fetal diastolic function ; Fetal Diseases - diagnostic imaging ; Fetal Diseases - physiopathology ; Fetal Heart - diagnostic imaging ; Fetal Heart - physiopathology ; fetal myocardial hypertrophy ; Gynecology. Andrology. Obstetrics ; Heart Atria - diagnostic imaging ; Heart Atria - physiopathology ; Humans ; left atrial shortening fraction ; maternal diabetes ; Medical sciences ; Myocardial Contraction ; Pregnancy ; Pregnancy in Diabetics ; Ultrasonography, Prenatal ; Ventricular Dysfunction, Left - diagnostic imaging ; Ventricular Dysfunction, Left - physiopathology</subject><ispartof>Ultrasound in obstetrics &amp; gynecology, 2009-02, Vol.33 (2), p.182-187</ispartof><rights>Copyright © 2008 ISUOG. Published by John Wiley &amp; Sons, Ltd.</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3494-12309a484a2033c9a97741b2a2eed1f236be03bd4de90a1d532128e2074590703</citedby><cites>FETCH-LOGICAL-c3494-12309a484a2033c9a97741b2a2eed1f236be03bd4de90a1d532128e2074590703</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=21107887$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19012275$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zielinsky, P.</creatorcontrib><creatorcontrib>Luchese, S.</creatorcontrib><creatorcontrib>Manica, J. L.</creatorcontrib><creatorcontrib>Piccoli, A. L.</creatorcontrib><creatorcontrib>Nicoloso, L. H.</creatorcontrib><creatorcontrib>Leite, M. F.</creatorcontrib><creatorcontrib>Hagemann, L.</creatorcontrib><creatorcontrib>Busato, A.</creatorcontrib><creatorcontrib>Moraes, M. R.</creatorcontrib><title>Left atrial shortening fraction in fetuses with and without myocardial hypertrophy in diabetic pregnancies</title><title>Ultrasound in obstetrics &amp; gynecology</title><addtitle>Ultrasound Obstet Gynecol</addtitle><description>Objective To test the hypothesis that, in diabetic pregnancies, left atrial shortening fraction (LASF) is decreased in fetuses with myocardial hypertrophy, compared to those without hypertrophy and to fetuses of non‐diabetic mothers. Methods Fetal echocardiography was performed in women with pre‐existing or gestational diabetes and in non‐diabetic controls between 25 weeks' gestation and term. LASF was calculated using the formula: (end‐systolic diameter—end‐diastolic diameter)/end‐systolic diameter, and data were compared between diabetic women with and without fetal myocardial hypertrophy and controls. Results The study population comprised 53 diabetic women and 45 controls. Out of the 53 fetuses of diabetic women, 14 had myocardial hypertrophy and 39 had normal septal thickness. Gestational age at the time of examination did not differ significantly between the control group and the two diabetic subgroups (P = 0.57). Fetuses with myocardial hypertrophy presented a mean ( ± SD) LASF of 0.32 ± 0.11, those without myocardial hypertrophy 0.46 ± 0.12, and those of normal mothers 0.53 ± 0.09 (P &lt; 0.001). A significant inverse linear correlation was observed between LASF and septal thickness (r = − 0.51, P &lt; 0.001). Conclusions In diabetic pregnancies, LASF is lower in fetuses with myocardial hypertrophy than it is in those without hypertrophy and in fetuses of non‐diabetic women, suggesting that LASF could be a useful alternative parameter in the assessment of fetal diastolic function. Copyright © 2008 ISUOG. Published by John Wiley &amp; Sons, Ltd.</description><subject>Biological and medical sciences</subject><subject>Cardiomegaly - diagnostic imaging</subject><subject>Cardiomegaly - physiopathology</subject><subject>Case-Control Studies</subject><subject>Cross-Sectional Studies</subject><subject>Diabetes Mellitus - diagnostic imaging</subject><subject>Diabetes Mellitus - physiopathology</subject><subject>Diabetes. Impaired glucose tolerance</subject><subject>Echocardiography</subject><subject>Endocrine pancreas. Apud cells (diseases)</subject><subject>Endocrinopathies</subject><subject>Etiopathogenesis. Screening. Investigations. Target tissue resistance</subject><subject>Female</subject><subject>fetal diastolic function</subject><subject>Fetal Diseases - diagnostic imaging</subject><subject>Fetal Diseases - physiopathology</subject><subject>Fetal Heart - diagnostic imaging</subject><subject>Fetal Heart - physiopathology</subject><subject>fetal myocardial hypertrophy</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Heart Atria - diagnostic imaging</subject><subject>Heart Atria - physiopathology</subject><subject>Humans</subject><subject>left atrial shortening fraction</subject><subject>maternal diabetes</subject><subject>Medical sciences</subject><subject>Myocardial Contraction</subject><subject>Pregnancy</subject><subject>Pregnancy in Diabetics</subject><subject>Ultrasonography, Prenatal</subject><subject>Ventricular Dysfunction, Left - diagnostic imaging</subject><subject>Ventricular Dysfunction, Left - physiopathology</subject><issn>0960-7692</issn><issn>1469-0705</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNp1kE1r3DAQhkVJaTZpob-g6JKSi9PRhyXrWEKaFhZyac5Glse7Cl7LlWSC_33s7JKecppheGZe5iHkK4MbBsB_TGF3o1gpP5ANk8oUoKE8IxswCgqtDD8nFyk9AYCSQn0i58wA41yXG_K0xS5Tm6O3PU37EDMOftjRLlqXfRioH2iHeUqY6LPPe2qH9rUJU6aHOTgb23V1P48Ycwzjfl5XllmD2Ts6RtwNdnAe02fysbN9wi-nekkef939vf1dbB_u_9z-3BZOSCMLxgUYKytpOQjhjDVaS9ZwyxFb1nGhGgTRtLJFA5a1peCMV8hBy9Isj4tL8v14d4zh34Qp1wefHPa9HTBMqVaq0qUWegGvj6CLIaWIXT1Gf7BxrhnUq9d68VqvXhf02-nm1Byw_Q-eRC7A1Qmwydl-0bf8nN44zhjoqloziyP37Huc3w2sHx_uX4NfAPR3j0g</recordid><startdate>200902</startdate><enddate>200902</enddate><creator>Zielinsky, P.</creator><creator>Luchese, S.</creator><creator>Manica, J. L.</creator><creator>Piccoli, A. L.</creator><creator>Nicoloso, L. H.</creator><creator>Leite, M. F.</creator><creator>Hagemann, L.</creator><creator>Busato, A.</creator><creator>Moraes, M. R.</creator><general>John Wiley &amp; Sons, Ltd</general><general>Wiley</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200902</creationdate><title>Left atrial shortening fraction in fetuses with and without myocardial hypertrophy in diabetic pregnancies</title><author>Zielinsky, P. ; Luchese, S. ; Manica, J. L. ; Piccoli, A. L. ; Nicoloso, L. H. ; Leite, M. F. ; Hagemann, L. ; Busato, A. ; Moraes, M. R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3494-12309a484a2033c9a97741b2a2eed1f236be03bd4de90a1d532128e2074590703</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Biological and medical sciences</topic><topic>Cardiomegaly - diagnostic imaging</topic><topic>Cardiomegaly - physiopathology</topic><topic>Case-Control Studies</topic><topic>Cross-Sectional Studies</topic><topic>Diabetes Mellitus - diagnostic imaging</topic><topic>Diabetes Mellitus - physiopathology</topic><topic>Diabetes. Impaired glucose tolerance</topic><topic>Echocardiography</topic><topic>Endocrine pancreas. Apud cells (diseases)</topic><topic>Endocrinopathies</topic><topic>Etiopathogenesis. Screening. Investigations. Target tissue resistance</topic><topic>Female</topic><topic>fetal diastolic function</topic><topic>Fetal Diseases - diagnostic imaging</topic><topic>Fetal Diseases - physiopathology</topic><topic>Fetal Heart - diagnostic imaging</topic><topic>Fetal Heart - physiopathology</topic><topic>fetal myocardial hypertrophy</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Heart Atria - diagnostic imaging</topic><topic>Heart Atria - physiopathology</topic><topic>Humans</topic><topic>left atrial shortening fraction</topic><topic>maternal diabetes</topic><topic>Medical sciences</topic><topic>Myocardial Contraction</topic><topic>Pregnancy</topic><topic>Pregnancy in Diabetics</topic><topic>Ultrasonography, Prenatal</topic><topic>Ventricular Dysfunction, Left - diagnostic imaging</topic><topic>Ventricular Dysfunction, Left - physiopathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zielinsky, P.</creatorcontrib><creatorcontrib>Luchese, S.</creatorcontrib><creatorcontrib>Manica, J. L.</creatorcontrib><creatorcontrib>Piccoli, A. L.</creatorcontrib><creatorcontrib>Nicoloso, L. H.</creatorcontrib><creatorcontrib>Leite, M. F.</creatorcontrib><creatorcontrib>Hagemann, L.</creatorcontrib><creatorcontrib>Busato, A.</creatorcontrib><creatorcontrib>Moraes, M. R.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Ultrasound in obstetrics &amp; gynecology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zielinsky, P.</au><au>Luchese, S.</au><au>Manica, J. L.</au><au>Piccoli, A. L.</au><au>Nicoloso, L. H.</au><au>Leite, M. F.</au><au>Hagemann, L.</au><au>Busato, A.</au><au>Moraes, M. R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Left atrial shortening fraction in fetuses with and without myocardial hypertrophy in diabetic pregnancies</atitle><jtitle>Ultrasound in obstetrics &amp; gynecology</jtitle><addtitle>Ultrasound Obstet Gynecol</addtitle><date>2009-02</date><risdate>2009</risdate><volume>33</volume><issue>2</issue><spage>182</spage><epage>187</epage><pages>182-187</pages><issn>0960-7692</issn><eissn>1469-0705</eissn><abstract>Objective To test the hypothesis that, in diabetic pregnancies, left atrial shortening fraction (LASF) is decreased in fetuses with myocardial hypertrophy, compared to those without hypertrophy and to fetuses of non‐diabetic mothers. Methods Fetal echocardiography was performed in women with pre‐existing or gestational diabetes and in non‐diabetic controls between 25 weeks' gestation and term. LASF was calculated using the formula: (end‐systolic diameter—end‐diastolic diameter)/end‐systolic diameter, and data were compared between diabetic women with and without fetal myocardial hypertrophy and controls. Results The study population comprised 53 diabetic women and 45 controls. Out of the 53 fetuses of diabetic women, 14 had myocardial hypertrophy and 39 had normal septal thickness. Gestational age at the time of examination did not differ significantly between the control group and the two diabetic subgroups (P = 0.57). Fetuses with myocardial hypertrophy presented a mean ( ± SD) LASF of 0.32 ± 0.11, those without myocardial hypertrophy 0.46 ± 0.12, and those of normal mothers 0.53 ± 0.09 (P &lt; 0.001). A significant inverse linear correlation was observed between LASF and septal thickness (r = − 0.51, P &lt; 0.001). Conclusions In diabetic pregnancies, LASF is lower in fetuses with myocardial hypertrophy than it is in those without hypertrophy and in fetuses of non‐diabetic women, suggesting that LASF could be a useful alternative parameter in the assessment of fetal diastolic function. Copyright © 2008 ISUOG. Published by John Wiley &amp; Sons, Ltd.</abstract><cop>Chichester, UK</cop><pub>John Wiley &amp; Sons, Ltd</pub><pmid>19012275</pmid><doi>10.1002/uog.6154</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0960-7692
ispartof Ultrasound in obstetrics & gynecology, 2009-02, Vol.33 (2), p.182-187
issn 0960-7692
1469-0705
language eng
recordid cdi_proquest_miscellaneous_66875737
source Wiley
subjects Biological and medical sciences
Cardiomegaly - diagnostic imaging
Cardiomegaly - physiopathology
Case-Control Studies
Cross-Sectional Studies
Diabetes Mellitus - diagnostic imaging
Diabetes Mellitus - physiopathology
Diabetes. Impaired glucose tolerance
Echocardiography
Endocrine pancreas. Apud cells (diseases)
Endocrinopathies
Etiopathogenesis. Screening. Investigations. Target tissue resistance
Female
fetal diastolic function
Fetal Diseases - diagnostic imaging
Fetal Diseases - physiopathology
Fetal Heart - diagnostic imaging
Fetal Heart - physiopathology
fetal myocardial hypertrophy
Gynecology. Andrology. Obstetrics
Heart Atria - diagnostic imaging
Heart Atria - physiopathology
Humans
left atrial shortening fraction
maternal diabetes
Medical sciences
Myocardial Contraction
Pregnancy
Pregnancy in Diabetics
Ultrasonography, Prenatal
Ventricular Dysfunction, Left - diagnostic imaging
Ventricular Dysfunction, Left - physiopathology
title Left atrial shortening fraction in fetuses with and without myocardial hypertrophy in diabetic pregnancies
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T00%3A46%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Left%20atrial%20shortening%20fraction%20in%20fetuses%20with%20and%20without%20myocardial%20hypertrophy%20in%20diabetic%20pregnancies&rft.jtitle=Ultrasound%20in%20obstetrics%20&%20gynecology&rft.au=Zielinsky,%20P.&rft.date=2009-02&rft.volume=33&rft.issue=2&rft.spage=182&rft.epage=187&rft.pages=182-187&rft.issn=0960-7692&rft.eissn=1469-0705&rft_id=info:doi/10.1002/uog.6154&rft_dat=%3Cproquest_cross%3E66875737%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3494-12309a484a2033c9a97741b2a2eed1f236be03bd4de90a1d532128e2074590703%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=66875737&rft_id=info:pmid/19012275&rfr_iscdi=true